Clinical Trial Update: 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating 131I-MIBG with myeloablative chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• 131I-MIBG (metaiodobenzylguanidine)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Neuroblastoma | Phase 1, Phase 2 | Status: UNKNOWN